Neertheless, the FDA approed Ketek entirely on the basis of noninferiority trials.

然而, FDA完全基于非初级实验就批准了Ketek上市.

互联网

By the end of 2006, Ketek had been implicated in 53 cases of hepatotoxic effects.

截至2006年底, Ketek已经涉及到了53例肝毒性效应.

互联网

The reiew of Ketek was thus marked by pronounced departures from accepted reiew practices.

最终,对Ketek的检查因被判为违背可接受的检查事实而记录下来.

互联网